Eli Lilly is slated to report first-quarter earnings before the bell on Thursday, in one of the most closely watched reports across the health-care sector.
The multinational conglomerate posted first-quarter adjusted operating income of 960 million euros ($1.19 billion), comfortably beating analyst expectations.